Studies on platelet membrane glycoproteins and platelet function during hemodialysis

Journal of the American Society of Nephrology

Volumn 8, Issue 5, 1997, Pages 799-803

  Sloand, James A ^a,c   Sloand, Elaine M ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Highland Hospital Rochester   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; UREMIA;

EID: 0030830371     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v85799     Document Type: Article

References (51)

1. Larsson SO: Coagulation and fibrinolysis in renal failure. Scand J Haematol 15: 1-59, 1971
2. Eknoyan G, Wacksman SJ, Glueck HI, Will JJ: Platelet function in renal failure. N Engl J Med 280: 677-681, 1969
3. Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G: Bleeding in renal failure: Altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 22: 347-353, 1978
4. Castaldi PA, Rozenberg MC, Stewart JH: The bleeding disorder of uraemia: A qualitative platelet defect. Lancet 2: 66-69, 1966
5. Salzman EW, Neri LL: Adhesiveness of blood platelets in uremia. Thromb Diath Haemorrh 15: 84-92, 1966
6. Horowitz HI, Stein IM, Cohen BD, White JG: Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. Am J Med 49: 336-345, 1970
7. Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, De Gaetano G, Day SS, Smith WL, Pinca E, Patrignani P, Patrono C: Reduced platelet thromboxane formation in uremia: Evidence for a functional cyclooxygenase defect. J Clin Invest 71: 762-768, 1983
8. Matthias FR, Palinski W: Prostaglandin-endoperoxides and cyclic 3′5′-AMP in platelets of patients with uremia. Thromb Haemost 38: 34, 1977
9. Lewis JH, Zucker MB, Ferguson JH: Bleeding tendency in uremia. Blood 11: 1073-1076, 1956
10. Sloand EM, Sloand JA, Prodouz K, Klein HG, Yu MW, Harvath L, Fricke W: Reduction of platelet glycoprotein Ib in uraemia. Br J Haematol 77: 375-381, 1991
11. Remuzzi G, Cavenaghi AE, Mecca G, Donati MB, de Gaetano G: Prostacyclin-like activity and bleeding in renal failure. Lancet 2: 1195-1197, 1977
12. Cheney K, Bonnin JA: Haemorrhage, platelet dysfunction and other coagulation defects in uraemia. Br J Haematol 8: 215-222, 1962
13. Gallice P, Fournier N, Crevat A, Briot M, Frayssinet R, Murisasco A: "In vitro" inhibition of platelet aggregation by uremic middle molecules. Biomedicine 33: 185-188, 1980
14. Remuzzi G: Bleeding disorders in uremia: Pathophysiology and treatment. Adv Nephrol 18: 171-186, 1989
15. Carvalho AC: Acquired platelet dysfunction in patients with uremia. Hematol Oncol Clin North Am 4: 129-143, 1990
16. Remuzzi G: Bleeding in renal failure. Lancet 1: 1205-1207, 1988
17. Lindsay RM, Friesen M, Koens F, Linton AL, Oreopoulos D, de Veber G: Platelet function in patients on long term peritoneal dialysis. Clin Nephrol 6: 335-339, 1976
18. Nenci GG, Berrettini M, Agnelli G, Parise P, Buoncristiani U, Ballatori E: Effect of peritoneal dialysis, hemodialysis and kidney transplantation on blood platelet function. Nephron 23: 287-292, 1979
19. Eknoyan G, Brown CH: Biochemical abnormalities of platelets in renal failure. Am J Nephrol 1: 17-23, 1981
20. Schmitt GW, Moake JL, Rudy CK, Vicks SL, Hamburger RJ: Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design: Platelet activation and factor VIII-related von Willebrand Factor during hemodialysis. Am J Med 83: 411-418, 1987
21. Docci D, Turci F, del Vecchio C, Bilancioni R, Cenciotti L, Pretolani E: Hemodialysis-associated platelet loss: Study of the relative contribution of dialyzer membrane composition and geometry. Int J Artif Organs 7: 337-340, 1986
22. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS: Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296: 769-774, 1977
23. Knudsen F, Nielsen AH, Kristensen SD: The effect of dialyzer membrane material on intradialytic changes in platelet count, platelet aggregation, circulating platelet aggregates and antithrombin III. Scand J Urol Nephrol 19: 227-232, 1985
24. Knudsen F, Dyerberg J: Platelets and antithrombin III in uraemia: The acute effect of hemodialysis. Scand J Clin Lab Invest 45: 341-347, 1985
25. 2 and Di-butyryl cyclic-AMP on platelets exposed to shear stress. Trans Am Soc Artif Intern Organs 27: 192-195, 1981
26. Lohr JW, Schwab SJ: Minimizing hemorrhagic complications in dialysis patients. J Am Soc Nephrol 2: 961-975, 1991
27. Iseki K, Kinjo K, Kimura Y, Osowa A, Fukiyama K: Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 44: 1086-1090, 1993
28. Guzzo J, Niewiarowski S, Musial J, Basitl C, Grossman RA, Rao AK, Berman I, Paul D: Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. J Lab Clin Med 96: 102-113, 1980
29. Green D, Santhanam S, Krumlovsky FA, del Greco F: β-thromboglobulin in patients with chronic renal failure: Effect of hemodialysis. Thromb Haemost 41: 416, 1979
30. Itagaki I, Molina M, Hakim R: Platelet aggregation defects in hemodialysis (HD) patients. J Am Soc Nephrol 2: 330, 1991
31. Addonizio VP: Platelet function in cardiopulmonary bypass and artificial organs. Hematol Oncol Clin North Am 4: 145-239, 1990
32. George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ: Platelet surface glycoproteins: Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 78: 340-348, 1986
33. Stewart JH, Castaldi PA: Uremic bleeding: A reversible platelet defect corrected by dialysis. QJM 143: 409-423, 1967
34. Steiner RW, Coggins C, Carvalho ACA: Bleeding time in uremia: A useful test to assess clinical bleeding. Am J Hematol 7: 107-117, 1979
35. Coller BS, Franza BR, Gralnick HR: The pH dependence of quantitative ristocetin-induced platelet aggregation: Theoretical and practical implications - A new device for maintenance of platelet-rich plasma pH. Blood 47: 841-854, 1976
36. Sloand EM, Alyono D, Klein HG, Chang P, Yu M, Lightfoot FG, Kessler C: 1-deamino-8-D-arginine vasopressin (DDAVP) increases platelet expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass. Am J Hematol 46: 199-207, 1994
37. Ruan C, Du X, Xi X, Castaldi PA, Berndt MC: A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen. Blood 69: 510-577, 1987
38. Phillips DR, Charo IF, Parise LV, Fitzgerald LA: The platelet membrane glycoprotein IIb-IIIa complex. Blood 71: 831-843, 1988
39. Du X, Beutler L, Ruan C, Castaldi PA, Berndt MC: Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 69: 1524-1527, 1987
40. Nieuwenhuis HK, van Oosterhout JJG, Rozemuller E van Iwaarden F, Sixma JJ: Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70: 838-845, 1987
41. Ljungberg B, Beving H, Egberg N, Johnsson H, Vesterqvist O: Immediate effects of heparin and LMW heparin on some platelet and endothelial derived factors. Thromb Res 51: 209-217, 1988
42. Sobel M, McNeill PM, Carlson PL, Kermode JC, Adelman B, Conroy R, Marques D: Heparin inhibition of von Willebrand Factor-dependent platelet function in vitro and in vivo. J Clin Invest 87: 1787-1793, 1991
43. Zucker MB: Biological aspects of heparin action. Heparin and platelet function. Fed Proc 36: 47-49, 1977
44. Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS: Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound. Blood 77: 770-779, 1991
45. Michelson AD, Barnard MR: Plasmin-induced redistribution of platelet glycoprotein Ib. Blood 76: 2005-2010, 1990
46. Michelson AD, Adelman B, Barnard MR, Carroll E, Handin RI: Platelet storage results in a redistribution of glycoprotein Ib molecules: Evidence for a large intraplatelet pool of glycoprotein Ib. J Clin Invest 81: 1734-1738, 1988
47. Krawczyk W, Dmoszynska A. Marczewski K, Rozyc P: Change of platelet function after the beginning of repeated hemodialysis treatment in patients with uremia. Pol Arch Med Wewn 92: 483-488, 1994
48. McCoy TJ, Wabers HD, Cooper SL: Series shunt evaluation of polyurethane vascular graft material in chronically AV-shunted canines. J Biomed Mater Res 24: 107-129, 1990
49. Jokl R, Klein RL, Lopes-Virella MF, Colwell JA: Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes. Diabetes Care 1150-1155, 1995
50. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL: Shear-induced platelet aggregation requires von Willebrand Factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 69: 625-628, 1987
51. Rinder HM, Murphy M, Mitchell JG, Stocks J, Ault KA, Hillman RS: Progressive platelet activation with storage: Evidence for shortened survival of activated platelets after transfusion. Transfusion 31: 409-414, 1991